Cost-Effectiveness Analysis of Biomarker-Guided Treatment for Metastatic Gastric Cancer in the Second-Line Setting

Journal of Oncology
Brianna LaurenChin Hur

Abstract

The 5-year survival rate of patients with metastatic gastric cancer (GC) is only 5%. However, trials have demonstrated promising antitumor activity for targeted therapies/immunotherapies among chemorefractory metastatic GC patients. Pembrolizumab has shown particular efficacy among patients with programmed death ligand-1 (PD-L1) expression and high microsatellite instability (MSI-H). The aim of this study was to assess the effectiveness and cost-effectiveness of biomarker-guided second-line GC treatment. We constructed a Markov decision-analytic model using clinical trial data. Our model compared pembrolizumab monotherapy and ramucirumab/paclitaxel combination therapy for all patients and pembrolizumab for patients based on MSI status or PD-L1 expression. Paclitaxel monotherapy and best supportive care for all patients were additional comparators. Costs of drugs, treatment administration, follow-up, and management of adverse events were estimated from a US payer perspective. The primary outcomes were quality-adjusted life years (QALYs) and incremental cost-effectiveness ratios (ICERs) with a willingness-to-pay threshold of $100,000/QALY over 60 months. Secondary outcomes were unadjusted life years (survival) and costs. Determin...Continue Reading

References

Dec 25, 2007·Health and Quality of Life Outcomes·A Simon PickardDavid Cella
Jun 10, 2010·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Amin HaideraliJessica Wegner
Feb 22, 2011·Journal of Gastroenterology and Hepatology·Hyunki KimHoguen Kim
Jun 14, 2012·The British Journal of Nutrition·Karla Sánchez-LaraDan Green
Mar 27, 2013·PharmacoEconomics·Fatiha H ShabaruddinKatherine Payne
Aug 1, 2014·Nature·UNKNOWN Cancer Genome Atlas Research Network
Aug 28, 2014·The New England Journal of Medicine·Peter J NeumannMilton C Weinstein
Sep 16, 2014·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayFreddie Bray
Mar 21, 2015·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Lisa M HessSteven Nicol
Apr 22, 2015·The New England Journal of Medicine·Caroline RobertUNKNOWN KEYNOTE-006 investigators
Jun 2, 2015·The New England Journal of Medicine·Dung T LeLuis A Diaz
Jan 9, 2016·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Mar 19, 2016·Asia-Pacific Journal of Clinical Oncology·Beenish NafeesMaria Lorenzo
Mar 25, 2016·Oncotarget·Christine BögerChristoph Röcken
Apr 14, 2016·Medical Oncology·Daniel A GoldsteinAnne M Noonan
Oct 18, 2016·Journal of Gastrointestinal Oncology·Zhaohui Jin, Harry H Yoon
Aug 2, 2017·BioMed Research International·Letizia ProcaccioSara Lonardi
Nov 11, 2017·Cancer Discovery·Yelena Y JanjigianNikolaus Schultz
Jan 11, 2018·The New England Journal of Medicine·Michael A PostowMatthew D Hellmann
Jun 9, 2018·Lancet·Elizabeth C Smyth, Russell D Petty
Aug 24, 2018·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E C Smyth, A Cervantes
Sep 3, 2018·Cellular and Molecular Life Sciences : CMLS·Margherita RattiNicola Valeri
Sep 23, 2018·Health and Quality of Life Outcomes·Eytan M SteinGeorge J Joseph
Dec 24, 2018·Nature Reviews. Clinical Oncology·Florian Lordick, Elizabeth C Smyth

❮ Previous
Next ❯

Citations

May 19, 2021·Journal of Translational Medicine·Qianmei FuJijiang Liu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.